NCT02625701View on ClinicalTrials.gov

Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Complication, Postoperative
Interventions
PROCEDURE

Goal-directed therapy

Optimize CO with additional fluid according to dynamic indices (PPV, SVV, Stroke volume)

PROCEDURE

Restrictive fluid therapy

Keep normovolemia with basal crystalloids infusion (3-6 ml/kg/h) and compensate additional fluid losses with colloids or crystalloids.

Trial Locations (1)

1211

University Hospital of Geneva, Department of Anesthesiology, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT02625701 - Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy | Biotech Hunter | Biotech Hunter